These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1499659)

  • 1. Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra.
    Stamidis H; Young GA
    Eur J Pharmacol; 1992 Mar; 213(1):9-16. PubMed ID: 1499659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-delta opioid interactions. III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole.
    Stamidis H; Young GA
    Peptides; 1993; 14(3):511-7. PubMed ID: 8392719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-delta opioid interactions. II: Beta-FNA inhibits DPDPE-induced increases in morphine EEG and EEG spectral power.
    Stamidis H; Young GA
    Peptides; 1992; 13(4):755-60. PubMed ID: 1331999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
    Paquette NC; Young GA
    Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively.
    Hudson GM; Marquis KL; Stamidis H; Young GA
    Eur J Pharmacol; 1992 Oct; 221(2-3):217-22. PubMed ID: 1426001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
    Hong O; Young GA; Khazan N
    Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-delta opioid interactions. I: The delta peptide, DPDPE, increases morphine-induced EEG and EEG spectral power.
    Stamidis H; Young GA
    Peptides; 1992; 13(4):749-53. PubMed ID: 1331998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
    Abdelhamid EE; Sultana M; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1991 Jul; 258(1):299-303. PubMed ID: 1649297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine.
    Noble F; Turcaud S; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1992 Nov; 223(1):83-9. PubMed ID: 1478260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats.
    Hepburn MJ; Little PJ; Gingras J; Kuhn CM
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1350-6. PubMed ID: 9190871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole.
    Menkens K; Bilsky EJ; Wild KD; Portoghese PS; Reid LD; Porreca F
    Eur J Pharmacol; 1992 Aug; 219(2):345-6. PubMed ID: 1425962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
    Malmberg AB; Yaksh TL
    J Pharmacol Exp Ther; 1992 Oct; 263(1):264-75. PubMed ID: 1328610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro investigation of naltrindole, a delta-opioid antagonist.
    Ayres EA; Davis P; Burks TF
    Proc West Pharmacol Soc; 1990; 33():55-63. PubMed ID: 2177196
    [No Abstract]   [Full Text] [Related]  

  • 16. Antinociception after intracerebroventricular administration of naltrindole in the mouse.
    Stapelfeld A; Hammond DL; Rafferty MF
    Eur J Pharmacol; 1992 Apr; 214(2-3):273-6. PubMed ID: 1325358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats.
    Kitchen I; Pinker SR
    Br J Pharmacol; 1990 Aug; 100(4):685-8. PubMed ID: 2169936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    Neuropharmacology; 1984 May; 23(5):505-9. PubMed ID: 6330605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin A-(1-13)-morphine interactions: quantitative and qualitative EEG properties differ in morphine-naive vs. morphine-tolerant rats.
    Meng Y; Young GA
    Brain Res Bull; 1994; 33(3):255-65. PubMed ID: 7904888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic profiles of morphine-induced EEG, EEG power spectra, and behavior in two inbred rat strains.
    Mayo-Michelson L; Young GA
    Brain Res Bull; 1993; 30(1-2):79-84. PubMed ID: 8420638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.